U.S., Oct. 2 -- ClinicalTrials.gov registry received information related to the study (NCT07200518) titled 'Effect of Probiotics After Neurosurgery' on Sept. 18.
Brief Summary: The goal of this randomised controlled trial is to determine the effect of consuming a multistrain probiotic OMNi-BiOTiC(R) Hetox on improving the healing, pain management, and postsurgical complications after neurosurgery.
The main question it aims to answer is:
* Is the multistrain probiotic OMNi-BiOTiC(R) Hetox effective in in improving patient-reported disability after neurosurgery?
Researchers will compare the probiotic group and the placebo group to determine if the healing is significantly different between the groups.
Study Start Date: Oct. 01
Study Typ...